Table 1. Specifications on human brain tissue samples.
| Case No. | Age | Sex | Braak Stage | PMI | MMSE | Diagnosis |
|---|---|---|---|---|---|---|
| 34 | 91 | F | 3 | 3.33 | 30 | NAD |
| 29 | 83 | F | 4 | 5.25 | 30 | NAD |
| 41 | 91 | F | 4 | 4.82 | 29 | NAD |
| 40 | 91 | F | 2 | 3.8 | 29 | NAD |
| 24 | 86 | F | 3 | 2.92 | 22 | MCI |
| 17 | 86 | F | 3 | 6.17 | 30 | MCI |
| 9 | 87 | M | 5 | 6.17 | 24 | MCI |
| 35 | 94 | M | 1 | 3.87 | 27 | MCI |
| 45 | 95 | F | 5 | 5.30 | 24 | MCI |
| 12 | 82 | F | 6 | 5.92 | 17 | LAD |
| 39 | 90 | M | 6 | 4.17 | 14 | LAD |
| 37 | 88 | F | 5 | 4.50 | 10 | LAD |
| 10 | 82 | F | 6 | 4.58 | −5 | LAD |
| 40 | 96 | F | 6 | 4.50 | 20 | LAD |
Details of the brain samples used in the study are provided in this table. PMI indicates post mortem interval. MMSE indicates clinical assessment using The Mini Mental State Examination. NAD: Non-Alzheimer's Disease (normal samples); MCI: Mild Cognitive Impairment; LAD: Late-stage Alzheimer's disease.